SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 282.09 |
Enterprise Value ($M) | 255.42 |
Book Value ($M) | 19.76 |
Book Value / Share | 0.47 |
Price / Book | 14.27 |
NCAV ($M) | 15.70 |
NCAV / Share | 0.37 |
Price / NCAV | 17.97 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.03 |
Return on Assets (ROA) | -0.98 |
Return on Equity (ROE) | -1.03 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 4.49 |
Current Ratio | 4.55 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 77.53 |
Assets | 81.60 |
Liabilities | 61.83 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 5.12 |
Operating Income | -63.22 |
Net Income | -67.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -38.58 |
Cash from Investing | -0.36 |
Cash from Financing | 74.21 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Avoro Capital Advisors LLC | 9.99 | ||
13G/A | Perceptive Advisors Llc | 16.90 | 40.89 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
35 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
15,287 | 53,141 | 28.77 | |
160,173 | 57,886 | 276.70 | |
8,238 | 38,499 | 21.40 | |
8,621 | 51,149 | 16.85 | |
41,603 | 105,626 | 39.39 | |
(click for more detail) |
Similar Companies | |
---|---|
VCEL – Vericel Corporation | VERA – Vera Therapeutics, Inc. |
VNDA – Vanda Pharmaceuticals Inc. | WVE – Wave Life Sciences Ltd. |
XENE – Xenon Pharmaceuticals Inc. |
Financial data and stock pages provided by
Fintel.io